אומפרה 10

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

OMEPRAZOLE 10 MG

Disponibbli minn:

RAFA LABORATORIES LTD

Kodiċi ATC:

A02BC01

Għamla farmaċewtika:

CAPSULES

Rotta amministrattiva:

PER OS

Manifatturat minn:

LABORATORIOS LICONSA S.A., SPAIN

Grupp terapewtiku:

OMEPRAZOLE

Indikazzjonijiet terapewtiċi:

Acute duodenal ulcer, Acute gastric ulcer, Helicobacter pylori associated peptic ulcer disease in combination with antibiotics. Reflux esophagitis: Treatment long-term management, Maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. Treatment of severe reflux esophagitis in children from one year of age and older. Maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. Zollinger-Ellison Syndrome. Treatment and prevention of NSAID-associated duodenal and gastric ulcer or erosions in high risk patients.

Data ta 'l-awtorizzazzjoni:

2012-06-01